Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
LEAP THERAPEUTICS, INC. (LPTX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/25/2023 |
4
| Dietz Thomas John (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 17,500 options to buy
@ $2.21, valued at
$38.7k
|
|
| 08/25/2023 |
4
| LI WILLIAM (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 15,000 options to buy
@ $2.21, valued at
$33.2k
|
|
| 08/25/2023 |
4
| Martin Patricia A. (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 15,000 options to buy
@ $2.21, valued at
$33.2k
|
|
| 08/25/2023 |
4
| LAWLOR AUGUSTINE (COO) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 70,000 options to buy
@ $2.21, valued at
$154.7k
|
|
| 08/25/2023 |
4
| Mashiach Nissim (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 15,000 options to buy
@ $2.21, valued at
$33.2k
|
|
| 08/25/2023 |
4
| Richard Christian M (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 15,000 options to buy
@ $2.21, valued at
$33.2k
|
|
| 08/25/2023 |
4
| Mirabelli Christopher (Chairman of the Board) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 70,000 options to buy
@ $2.21, valued at
$154.7k
|
|
| 08/25/2023 |
4
| ONSI DOUGLAS E (CEO,CFO,Pres.,GC,Treas.,&Sec.) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 140,000 options to buy
@ $2.21, valued at
$309.4k
|
|
| 08/25/2023 |
4
| Schilsky Richard (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 15,000 options to buy
@ $2.21, valued at
$33.2k
|
|
| 08/25/2023 |
4
| CAVANAUGH JAMES H (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 15,000 options to buy
@ $2.21, valued at
$33.2k
|
|
| 08/25/2023 |
4
| Granfield Christine (VP, Head of Reg Affairs/Qual) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 70,000 options to buy
@ $2.21, valued at
$154.7k
|
|
| 08/25/2023 |
4
| O'Mahony John Mark (Chief Manufacturing Officer) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 70,000 options to buy
@ $2.21, valued at
$154.7k
|
|
| 08/25/2023 |
4
| Baum Jason (Chief Scientific Officer) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 70,000 options to buy
@ $2.21, valued at
$154.7k
|
|
| 08/25/2023 |
4
| Sirard Cynthia (Chief Medical Officer) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 70,000 options to buy
@ $2.21, valued at
$154.7k
|
|
| 08/25/2023 |
4
| LOSCALZO JOSEPH (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 15,000 options to buy
@ $2.21, valued at
$33.2k
|
|
| 08/14/2023 |
8-K
| Quarterly results |
| 08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/12/2023 |
8-K
| Quarterly results |
| 06/09/2023 |
S-3/A
| Form S-3/A - Registration statement under Securities Act of 1933: [Amend] |
| 05/25/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 05/15/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/15/2023 |
8-K
| Quarterly results |
| 04/28/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/26/2023 |
8-K
| Quarterly results |
| 04/21/2023 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 04/14/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 04/04/2023 |
4
| Mirabelli Christopher (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 500,000 options to buy
@ $0.34, valued at
$170k
|
|
| 04/04/2023 |
4
| Sirard Cynthia (Chief Medical Officer) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 500,000 options to buy
@ $0.34, valued at
$170k
|
|
| 04/04/2023 |
4
| O'Mahony John Mark (Chief Manufacturing Officer) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 500,000 options to buy
@ $0.34, valued at
$170k
|
|
| 04/04/2023 |
4
| Granfield Christine (VP, Head of Reg Affairs/Qual) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 500,000 options to buy
@ $0.34, valued at
$170k
|
|
| 04/04/2023 |
4
| LOSCALZO JOSEPH (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 150,000 options to buy
@ $0.34, valued at
$51k
|
|
| 04/04/2023 |
4
| LI WILLIAM (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 150,000 options to buy
@ $0.34, valued at
$51k
|
|
| 04/04/2023 |
4
| CAVANAUGH JAMES H (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 150,000 options to buy
@ $0.34, valued at
$51k
|
|
| 04/04/2023 |
4
| Schilsky Richard (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 150,000 options to buy
@ $0.34, valued at
$51k
|
|
|
|
|